Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APD125 Subjective Study in Primary Insomnia
NCT00664664Phase 2Completed
- Sponsor
- Arena Pharmaceuticals, Inc.
- Start
- Apr 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nelotanserin in Insomnia, sponsored by Arena Pharmaceuticals, Inc.. Started Apr 2008; status: completed.
02
Drugs
nelotanserin
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00664664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00664664.